Department Of Defense Appropriations Act, 2015
Mr. Chairman, I thank the ranking member for yielding, and for your very hard work on this Department of Defense Appropriations bill. Mr. Chairman, as the daughter of a veteran, I know how important it is to fully fund and support our…
Mr. Chairman, I thank the ranking member for yielding, and for your very hard work on this Department of Defense Appropriations bill.
Mr. Chairman, as the daughter of a veteran, I know how important it is to fully fund and support our troops. I strongly support these provisions of this legislation.
With that said, though, there are many provisions in this bill which I cannot support. These include nearly $500 billion in discretionary funding, with an increase of $4 billion above the fiscal year 2014 enacted level, which we have not seen for any other appropriations bill this year.
This inflated level of spending fails to account, mind you, for the waste, fraud, and abuse that continue at the Pentagon. We must audit the Pentagon and reduce unnecessary Pentagon spending.
This bill also includes nearly $80 billion for the overseas contingency operations slush fund, which is what it is, at a time when the President has not even made a specific request about how much is needed. This is outrageous, and this slush fund should be eliminated.
Now I will be offering several amendments to this bill, one to limit operations in Afghanistan after 2014, as well as to repeal the 2001 blank check authorization.
The farm bill, transportation bill, other bills, other authorizations have end dates. We need to end this. Come back to Congress, debate what we are going to do in Iraq, if anything, in terms of military strikes and, in fact, repeal the authorization on Afghanistan passed in 2001.
Mr. Chairman, I have an amendment at the desk.
Mr. Chairman, I thank the chairman and the ranking member for working with me on this very important amendment. This is a very simple amendment that would provide a $5 million increase to available funds for research, development, testing, and evaluation related to multiple sclerosis under the Defense Health Program.
These funds would increase funding for multiple sclerosis research under DOD to $10 million. This amendment fulfills the request of $10 million for MS research that was included in a bipartisan letter signed by 78 Members of Congress earlier this year, including cochairs of the Congressional MS Caucus, Representative Michael Burgess and Representative Van Hollen, and I will include the Dear Colleague letter for the Record.
Congress of the United States,
Washington, DC, March 28, 2014.
Hon. Rodney Frelinghuysen,
Chairman, Subcommittee on Defense Committee on
Appropriations, Washington, DC.
Hon. Pete Visclosky,
Ranking Member, Subcommittee on Defense Committee on
Appropriations, Washington, DC.
Dear Chairman Frelinghuysen and Ranking Member Visclosky:
On behalf of all people living with multiple sclerosis (MS),
we would like to thank you for your past support for funding
MS research through the Congressionally Directed Medical
Research Programs (CDMRP). As you know, MS is a chronic,
unpredictable, often disabling disease of the central nervous
system. MS is generally diagnosed between the ages of 20 and
50, during the prime of an individual's life. Sadly, the
cause of MS is still unknown and there is no cure. While we
recognize the fiscal constraints the country faces, it is
critical that we continue to fund this important research,
which holds great promise for our military service members
and all those who are affected by MS. We respectfully ask
that you direct $10 million to fund the MS research program
for Fiscal Year 2015.
MS interrupts the flow of information within the brain, and
between the brain and body. Every hour in the United States,
someone is newly diagnosed with the disease. Symptoms range
from numbness and tingling to blindness and paralysis. The
progress, severity and specific symptoms of MS in any one
person cannot yet be predicted, but advances in research are
improving the possibility of a world free of MS.
Currently, the FDA-approved treatments that are available
to treat MS only slow the progression of the disease for a
subset of the MS population. Of these available medical
treatments, many are not effective for patients and cannot be
tolerated by many others. Additionally, the cost of treating
and living with MS is costly--approximately $69,000 annually.
Many U.S. veterans have stories and symptoms of multiple
sclerosis. Preliminary evidence suggests that some combat
veterans could have an increased risk of developing MS.
Over 23,000 veterans are being treated for MS through the
Department of Veterans Affairs (VA).
A study in the Annals of Neurology identified 5,345 cases
of ``service-connected'' MS among U.S. veterans.
An epidemiologic study found a two-fold increase in MS
between 1993 and 2000 in Kuwait, which suggests a potential
environmental trigger for MS.
The VA is currently funding two MS Centers of Excellence to
provide clinical care and education for these veterans, but
now physicians at these institutions are seeking funding to
explore a potential link between MS and combat service.
MS research has the potential to help all those living with
MS, including our veterans. We ask that you support MS
research by including $10 million in funding for the MS
program within the, CDMRP in the Fiscal Year 2015 Defense
Appropriations. Thank you for your consideration of this
request.
Sincerely,
Michael C. Burgess, M.D., Henry C. ``Hank'' Johnson, Jr.,
Andree Carson, Daniel W. Lipinski, James R. Langevin, Charles
B. Rangel, Chris Van Hollen, Eliot L. Engel, Sander Levin,
Yvette D. Clarke, John Yarmuth, Frederica S. Wilson.
Peter DeFazio, Sheila Jackson Lee, Tony Cardenas,
Christopher H. Smith, Mike Michaud, Ron Kind, Brad Schneider,
Lloyd Doggett, Joe Courtney, Peter King, Jon Runyan, Alcee L.
Hastings, Rick Larsen, Barbara Lee, Donald M. Payne, Jr.,
Danny K. Davis, Ann MacLane Kuster, C.A. Dutch Ruppersberger.
Jan Schakowsky, Steve Israel, Michael Grimm, Carolyn
McCarthy, Steve Cohen, Luis V. Gutieerrez, Tim Bishop, Gerald
E. Connolly, Tim Murphy, Carol Shea-Porter, Stephen F. Lynch,
Rush Holt, Chellie Pingree, David N. Cicilline, Bill Foster,
Gloria Negrete McLeod, Jim McDermott, Elijah E. Cummings.
John F. Tierney, Chaka Fattah, Dave Loebsack, Matt
Cartwright, Juan Vargas, John Delaney, David Price, Jim
Himes, Julia Brownley, Lois Frankel, Collin C. Peterson, Alan
Grayson, Gregory W. Meeks, Spencer Bachus, John Garamendi,
Robert A. Brady, Marc Veasey, Cheri Bustos.
Mark Pocan, Elizabeth H. Esty, Ann Kirkpatrick, Susan A.
Davis, Dan Kildee, Dan Benishek, M.D., Ben Ray Lujaan, Ron
Barber, Grace Meng, Tim Walz, John Conyers, Jr., Mike
Thompson.
There are 2 million people worldwide living with MS. This complicated and unpredictable neurological disease interrupts the flow of information within the brain and between the brain and the body.
MS is a chronic disease that can often be debilitating for those living with it, and the symptoms of MS are as diverse as the people it impacts.
I am pleased to introduce this amendment to the Defense Appropriations bill, since MS has a significant impact on our armed services. Some 23,000 veterans are currently being treated for MS, with more than 5,000 cases having been identified as service connected.
Because of increased research funding in MS, the first disease- modifying drugs became available for people living with MS 20 years ago. However, these drugs only work for a subset of the population, and many people living with MS still have no viable treatment options.
Increased research funding could give scientists a better understanding of the disease, which could potentially unveil new therapies.
I will close by adding that I understand, on a very personal level, the impact of this disease. My sister, Mildred, shows me every day what life is like to live with the disease, and I am consistently amazed by her strength and her bravery. She and the millions of people around the world living with MS are really a testament to the importance of making stronger investments to find a cure.
Mr. Chairman, on behalf of my sister Mildred and on behalf of all of those living with MS, on behalf of the families and caregivers, I urge my colleagues to vote ``yes.''
I yield to the gentleman from New Jersey.
Mr. Chairman, I thank the gentleman, and I urge a ``yes'' vote.
I yield back the balance of my time.